All combinations of SINCP-neu or SINCP-βgal used as the prime and Adeno-neu and Adeno-empty used as the boost were tested in both the therapeutic mammary fat pad tumor model and the therapeutic experimental metastasis model. Here, ERBB2 is linked to neoplasm.